These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 32201888)

  • 21. Rewriting the transcriptome: adenosine-to-inosine RNA editing by ADARs.
    Walkley CR; Li JB
    Genome Biol; 2017 Oct; 18(1):205. PubMed ID: 29084589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ICLAMP: a novel technique to explore adenosine deamination via inosine chemical labeling and affinity molecular purification.
    Yang Y; Nakayama K; Okada S; Sato K; Wada T; Sakaguchi Y; Murayama A; Suzuki T; Sakurai M
    FEBS Lett; 2024 May; 598(9):1080-1093. PubMed ID: 38523059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A-to-I editing on tRNAs: biochemical, biological and evolutionary implications.
    Torres AG; Piñeyro D; Filonava L; Stracker TH; Batlle E; Ribas de Pouplana L
    FEBS Lett; 2014 Nov; 588(23):4279-86. PubMed ID: 25263703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulatory factors governing adenosine-to-inosine (A-to-I) RNA editing.
    Hong H; Lin JS; Chen L
    Biosci Rep; 2015 Mar; 35(2):. PubMed ID: 25662729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The adaptive potential of RNA editing-mediated miRNA-retargeting in cancer.
    Tassinari V; Cesarini V; Silvestris DA; Gallo A
    Biochim Biophys Acta Gene Regul Mech; 2019 Mar; 1862(3):291-300. PubMed ID: 30605729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ADAR-related activation of adenosine-to-inosine RNA editing during regeneration.
    Witman NM; Behm M; Ohman M; Morrison JI
    Stem Cells Dev; 2013 Aug; 22(16):2254-67. PubMed ID: 23534823
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Construction of a guide-RNA for site-directed RNA mutagenesis utilising intracellular A-to-I RNA editing.
    Fukuda M; Umeno H; Nose K; Nishitarumizu A; Noguchi R; Nakagawa H
    Sci Rep; 2017 Feb; 7():41478. PubMed ID: 28148949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteogenomics of Adenosine-to-Inosine RNA Editing in the Fruit Fly.
    Kuznetsova KG; Kliuchnikova AA; Ilina IU; Chernobrovkin AL; Novikova SE; Farafonova TE; Karpov DS; Ivanov MV; Goncharov AO; Ilgisonis EV; Voronko OE; Nasaev SS; Zgoda VG; Zubarev RA; Gorshkov MV; Moshkovskii SA
    J Proteome Res; 2018 Nov; 17(11):3889-3903. PubMed ID: 30298734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A-to-I editing of coding and non-coding RNAs by ADARs.
    Nishikura K
    Nat Rev Mol Cell Biol; 2016 Feb; 17(2):83-96. PubMed ID: 26648264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Redirection of silencing targets by adenosine-to-inosine editing of miRNAs.
    Kawahara Y; Zinshteyn B; Sethupathy P; Iizasa H; Hatzigeorgiou AG; Nishikura K
    Science; 2007 Feb; 315(5815):1137-40. PubMed ID: 17322061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using mouse models to unlock the secrets of non-synonymous RNA editing.
    Jinnah H; Ulbricht RJ
    Methods; 2019 Mar; 156():40-45. PubMed ID: 30827465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A-to-I editing in human miRNAs is enriched in seed sequence, influenced by sequence contexts and significantly hypoedited in glioblastoma multiforme.
    Paul D; Sinha AN; Ray A; Lal M; Nayak S; Sharma A; Mehani B; Mukherjee D; Laddha SV; Suri A; Sarkar C; Mukhopadhyay A
    Sci Rep; 2017 May; 7(1):2466. PubMed ID: 28550310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RNA editing of hepatitis delta virus antigenome by dsRNA-adenosine deaminase.
    Polson AG; Bass BL; Casey JL
    Nature; 1996 Apr; 380(6573):454-6. PubMed ID: 8602246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adenosine Deaminases That Act on RNA (ADARs).
    Wang Y; Zheng Y; Beal PA
    Enzymes; 2017; 41():215-268. PubMed ID: 28601223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Fluorescent Adenosine Analogue as a Substrate for an A-to-I RNA Editing Enzyme.
    Mizrahi RA; Shin D; Sinkeldam RW; Phelps KJ; Fin A; Tantillo DJ; Tor Y; Beal PA
    Angew Chem Int Ed Engl; 2015 Jul; 54(30):8713-6. PubMed ID: 26095193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A cytosine deaminase for programmable single-base RNA editing.
    Abudayyeh OO; Gootenberg JS; Franklin B; Koob J; Kellner MJ; Ladha A; Joung J; Kirchgatterer P; Cox DBT; Zhang F
    Science; 2019 Jul; 365(6451):382-386. PubMed ID: 31296651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Substrate recognition by ADAR1 and ADAR2.
    Wong SK; Sato S; Lazinski DW
    RNA; 2001 Jun; 7(6):846-58. PubMed ID: 11421361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The dynamic epitranscriptome: A to I editing modulates genetic information.
    Tajaddod M; Jantsch MF; Licht K
    Chromosoma; 2016 Mar; 125(1):51-63. PubMed ID: 26148686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolutionarily conserved human targets of adenosine to inosine RNA editing.
    Levanon EY; Hallegger M; Kinar Y; Shemesh R; Djinovic-Carugo K; Rechavi G; Jantsch MF; Eisenberg E
    Nucleic Acids Res; 2005; 33(4):1162-8. PubMed ID: 15731336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A-to-I RNA editing promotes developmental stage-specific gene and lncRNA expression.
    Goldstein B; Agranat-Tamir L; Light D; Ben-Naim Zgayer O; Fishman A; Lamm AT
    Genome Res; 2017 Mar; 27(3):462-470. PubMed ID: 28031250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.